
Opinion|Videos|May 17, 2024
Research Landscape: Endocrine Therapies for ER+/HER2- Metastatic Breast Cancer
Author(s)Stephanie L. Graff, MD
Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
2
Many US Health Care Workers Face Poverty, Food Insecurity, and Housing Instability
3
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
4
Combination Therapy Proves More Effective in NSCLC Compared With Chemotherapy
5